Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Actemra® (tocilizumab) – New indication
May 22, 2017 – The FDA announced the approval of Roche’s Actemra (tocilizumab) subcutaneous (SC) injection, for the treatment of adult patients with giant cell arteritis (GCA).
